Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123931) titled 'A Phase I Clinical Trial of YMN-A02 in Patients With Advanced pMMR Colorectal Cancer and Liver Metastases: Safety, Tolerability, and Preliminary Efficacy' on May 1.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Advanced pMMR Colorectal Cancer with Liver Metastases
Intervention:
The 100µg dose group of MN-A02 bifunctional RNA preparation:Enrolled subjects will receive a 100 µg intravenous infusion according to their assigned dose group. The dosing regimen includes 5 doses of primary immunization followed by subsequent ...